Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol versus Metohexal for prevention of postoperative atrial fibrillation after coronary artery bypass surgery
IRCT20210121050095N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Bisoprolol arm with Metohexal arm (2 arms). Primary endpoint: atrial fibrillation. Started Aug 2020; status: completed.
02
Drugs
bisoprololmetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20210121050095N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210121050095N1.